Healthy volunteers test drug interaction in Early-Stage trial
NCT ID NCT07308041
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This early-stage trial looked at how a new medicine for acid reflux (linaprazan glurate) affects the way the body processes the common antibiotic amoxicillin. Twelve healthy adults took both drugs and had their blood levels measured. The goal was to gather safety and drug interaction data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CTC Clinical Trial Consultants AB
Uppsala, 752 37, Sweden
Conditions
Explore the condition pages connected to this study.